News | January 18, 2024
Taro announces merger agreement with Sun Pharma
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The company received gross proceeds of approximately US$1.7 million and net proceeds,
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care
Furthering cell therapy ambition across oncology and autoimmune diseases
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Subscribe To Our Newsletter & Stay Updated
